Frontiers in Oncology | Thoracic Oncology

Clinical Trial

Published on 19 Sep 2017

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer

in Thoracic Oncology

Thierry Berghmans
Arnaud Scherpereel
Anne-Pascale Meert
Vicente Giner
Jacques Lecomte
Jean-Jacques Lafitte
Nathalie Leclercq
Marianne Paesmans
Jean-Paul Sculier
for the European Lung Cancer Working Party (ELCWP)

Frontiers in Oncology

doi 10.3389/fonc.2017.00217

4,944 views
9 citations

Review

Published on 01 Sep 2017

Smoking and Lung Cancer: A Geo-Regional Perspective

in Thoracic Oncology

Zahraa Rahal
Shaza El Nemr
Ansam Sinjab
Hassan Chami
Arafat Tfayli
Humam Kadara

Frontiers in Oncology

doi 10.3389/fonc.2017.00194

18,579 views
66 citations

Mini Review

Published on 28 Aug 2017

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

in Thoracic Oncology

Kentaro Inamura

Frontiers in Oncology

doi 10.3389/fonc.2017.00193

102,161 views
461 citations

Mini Review

Published on 13 Jun 2017

Low Grade Neuroendocrine Tumors of the Lung

in Thoracic Oncology

Barbara Melosky

Frontiers in Oncology

doi 10.3389/fonc.2017.00119

20,375 views
14 citations

Mini Review

Published on 31 May 2017

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

in Thoracic Oncology

Tristan A. Barnes
Grainne M. O’Kane
Mark David Vincent
Natasha B. Leighl

Frontiers in Oncology

doi 10.3389/fonc.2017.00113

15,987 views
56 citations

Original Research

Published on 30 May 2017

Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy

in Thoracic Oncology

Rohan Arora
Venkat Krishnan

Frontiers in Oncology

doi 10.3389/fonc.2017.00104

10,119 views
4 citations

Mini Review

Published on 16 May 2017

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib

in Thoracic Oncology

Sami Morin-Ben Abdallah
Vera Hirsh

Frontiers in Oncology

doi 10.3389/fonc.2017.00097

6,439 views
11 citations

Review

Published on 06 Apr 2017

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

in Thoracic Oncology

Marco A. J. Iafolla
Rosalyn A. Juergens

Frontiers in Oncology

doi 10.3389/fonc.2017.00067

8,904 views
26 citations

Mini Review

Published on 05 Apr 2017

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer

in Thoracic Oncology

Annick Wong

Frontiers in Oncology

doi 10.3389/fonc.2017.00033

7,209 views
16 citations

Mini Review

Published on 29 Mar 2017

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine

in Thoracic Oncology

Samer Tabchi
Normand Blais

Frontiers in Oncology

doi 10.3389/fonc.2017.00052

7,732 views
27 citations

Mini Review

Published on 27 Mar 2017

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine

in Thoracic Oncology

Sara Victoria Soldera
Natasha B. Leighl

Frontiers in Oncology

doi 10.3389/fonc.2017.00050

7,824 views
38 citations

Mini Review

Published on 20 Mar 2017

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer

in Thoracic Oncology

Barbara Melosky

Frontiers in Oncology

doi 10.3389/fonc.2017.00038

20,850 views
22 citations

Case Report

Published on 02 Mar 2017

Treating the Critically Ill with Radiotherapy: Lessons Learned from a Young Woman with Cardiac Angiosarcoma

in Thoracic Oncology

Emma C. Fields
Bryan Squires
Harry Lomas

Frontiers in Oncology

doi 10.3389/fonc.2017.00029

3,110 views
8 citations

Review

Published on 14 Feb 2017

Interventional Analgesic Management of Lung Cancer Pain

in Thoracic Oncology

Uri Hochberg
Maria Francisca Elgueta
Jordi Perez

Frontiers in Oncology

doi 10.3389/fonc.2017.00017

23,726 views
43 citations

Clinical Trial

Published on 20 Dec 2016

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Hongmei Lin
Yuhchyau Chen
Anhui Shi
Kishan J Pandya
Rong Yu
Yannan Yuan
Jiancheng Li
Hang Li
Yingjie Wang
Tingyi Xia

Frontiers in Oncology

doi 10.3389/fonc.2016.00260

5,088 views
11 citations

Mini Review

Published on 14 Nov 2016

Recent Advances in Immunotherapy in Metastatic NSCLC

in Thoracic Oncology

Pranshu Bansal
Diaa Osman
Gregory N. Gan
George R. Simon
Yanis Boumber

Frontiers in Oncology

doi 10.3389/fonc.2016.00239

11,382 views
39 citations

Perspective

Published on 24 Oct 2016

Report on First International Workshop on Robotic Surgery in Thoracic Oncology

in Thoracic Oncology

Giulia Veronesi
Robert Cerfolio
Roberto Cingolani
Jens C. Rueckert
Luc Soler
Alper Toker
Umberto Cariboni
Edoardo Bottoni
Uberto Fumagalli
Franca Melfi

Frontiers in Oncology

doi 10.3389/fonc.2016.00214

8,717 views
30 citations

Case Report

Published on 24 Oct 2016

Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review

in Thoracic Oncology

Sarah A. Dooley
Carryn M. Anderson

Frontiers in Oncology

doi 10.3389/fonc.2016.00219

3,686 views
4 citations

Mini Review

Published on 04 May 2016

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC

in Thoracic Oncology

Pranshu Bansal
Diaa Osman
Gregory N. Gan
George R. Simon
Yanis Boumber

Frontiers in Oncology

doi 10.3389/fonc.2016.00112

10,629 views
30 citations

Clinical Trial

Published on 13 Jan 2016

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

in Thoracic Oncology

Chao H. Huang
Stephen K. Williamson
Prakash Neupane
Sarah A. Taylor
Ace Allen
Nora J. Smart
Adelina M. Uypeckcuat
Sarah Spencer
Jo Wick
Holly Smith

Frontiers in Oncology

doi 10.3389/fonc.2015.00301

4,861 views
11 citations

Editorial

Published on 30 Nov 2015

Novel Treatments for Thymoma and Thymic Carcinoma

in Thoracic Oncology

Arun Rajan
Heather Wakelee
Giuseppe Giaccone

Frontiers in Oncology

doi 10.3389/fonc.2015.00267

6,236 views
1 citation

Review

Published on 30 Sep 2015

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions

in Thoracic Oncology

Zhuo Zhang
Nithya Ramnath
Sunitha Nagrath

Frontiers in Oncology

doi 10.3389/fonc.2015.00209

18,983 views
60 citations

Review

Published on 22 Sep 2015

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

in Thoracic Oncology

Annkathrin Hanssen
Sonja Loges
Klaus Pantel
Harriet Wikman

Frontiers in Oncology

doi 10.3389/fonc.2015.00207

14,645 views
68 citations

Original Research

Published on 26 May 2015

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States

in Thoracic Oncology

Anish Thomas
Yuanbin Chen
Tinghui Yu
Marko Jakopovic
Giuseppe Giaccone

Frontiers in Oncology

doi 10.3389/fonc.2015.00113

17,011 views
113 citations

1,970 articles

articles

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer

Smoking and Lung Cancer: A Geo-Regional Perspective

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

Low Grade Neuroendocrine Tumors of the Lung

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine

Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer

Treating the Critically Ill with Radiotherapy: Lessons Learned from a Young Woman with Cardiac Angiosarcoma

Interventional Analgesic Management of Lung Cancer Pain

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

Recent Advances in Immunotherapy in Metastatic NSCLC

Report on First International Workshop on Robotic Surgery in Thoracic Oncology

Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

Novel Treatments for Thymoma and Thymic Carcinoma

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States